Form 4: Vicarious Surgical Director Granted Stock Options

Vicarious Surgical Inc. director David D. Ho was granted 5,335 stock options with an exercise price of $7.61, vesting in June 2026.

Summary

• David D. Ho, a Director and 10% Owner of Vicarious Surgical Inc. (RBOT), was granted 5,335 stock options.
• The stock options have an exercise price of $7.61 per share.
• The options were acquired on June 27, 2025, with a derivative security price of $0.00.
• All 5,335 shares underlying the option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier.
• Vesting is contingent upon Mr. Ho's continued service through the applicable vesting date.
• The options have an expiration date of June 26, 2035.
• Following this transaction, Mr. Ho beneficially owns 5,335 derivative securities.

Sentiment

Score: 6

Explanation: Slightly positive. The grant of stock options to a director is a standard practice that aligns management incentives with shareholder interests, indicating stability in governance and a commitment to long-term value creation, though the immediate impact is minimal.

Positives

• The grant of stock options aligns the interests of Director David D. Ho with those of the shareholders, incentivizing long-term performance.
• This compensation mechanism can aid in the retention of key board members.

Negatives

• The issuance of new stock options, upon exercise, could lead to minor dilution for existing shareholders, although the amount is small in this instance.

Risks

• The vesting of options is subject to the reporting person's continued service, meaning the benefit is contingent on ongoing employment or board membership.
• The value of the options is dependent on the future stock price of Vicarious Surgical Inc. exceeding the exercise price of $7.61.

Future Outlook

The stock options are set to vest on June 27, 2026, or earlier, contingent on the director's continued service, providing a future incentive for performance.

Industry Context

This is a routine compensation event for a director of a publicly traded company, common across various industries to align executive and board interests with shareholder value creation.

Comparison to Industry Standards

• The grant of stock options as part of director compensation is a standard practice in the medical technology and robotics industry, similar to companies like Intuitive Surgical (ISRG) or Stryker (SYK) which also utilize equity-based incentives for their leadership.
• The vesting schedule tied to continued service is typical for such grants, ensuring retention and long-term commitment from board members.
• The exercise price of $7.61 reflects the stock price at the time of grant, a common method for determining option strike prices in compensation packages.

Related Party Transactions

• The grant of stock options to David D. Ho, a Director and 10% Owner, constitutes a related party transaction as it involves compensation to a key management person.

Stakeholder Impact

• Shareholders: Potential for minor dilution upon exercise of options, but also benefit from increased alignment of director's interests with long-term stock performance.
• Director (David D. Ho): Receives a significant equity incentive tied to the company's future stock performance, enhancing personal wealth potential.

Next Steps

• The stock options will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to continued service.

Key Dates

Recommendation

This Form 4 filing details a routine stock option grant to a director, which is a standard compensation practice and does not provide sufficient new information to warrant a change in investment recommendation. It primarily indicates ongoing corporate governance and incentive alignment rather than a material change in the company's operational or financial outlook.

Keywords

Vicarious Surgical, RBOT, Stock Options, SEC Form 4, Director Compensation, Beneficial Ownership, Equity Grant, Corporate Governance